Loading...
•
Jun 30
Sight Sciences Q2 2025 Earnings Report
Sight Sciences reported its second quarter 2025 financial results, including a decrease in total revenue and net loss, while raising its full-year 2025 revenue guidance.
Key Takeaways
Sight Sciences reported a total revenue of $19.6 million for Q2 2025, an 8% decrease year-over-year, primarily due to lower Surgical Glaucoma revenue impacted by Medicare coverage restrictions. Despite this, the company reduced operating expenses and saw an increase in Surgical Glaucoma ordering accounts, leading to a slightly improved net loss.
Total revenue for Q2 2025 was $19.6 million, an 8% decrease compared to the prior year, mainly due to a decline in the Surgical Glaucoma segment.
Operating expenses were reduced by 9% to $28.3 million in Q2 2025, primarily due to lower legal expenses.
Surgical Glaucoma ordering accounts reached an all-time high of 1,174, up 4% year-over-year.
Net loss improved slightly to $11.9 million, or $0.23 per share, compared to $12.3 million, or $0.25 per share, in Q2 2024.
Sight Sciences
Sight Sciences
Sight Sciences Revenue by Segment
Revenue by Segment
Surgical Glaucoma Revenue
CapyFin.comDry Eye Revenue
CapyFin.com Forward Guidance
Sight Sciences raised its full-year 2025 revenue guidance to $72.0 million to $76.0 million, while reaffirming its adjusted operating expenses guidance of $101.0 million to $105.0 million.
Positive Outlook
- Raised full-year 2025 revenue guidance, indicating improved outlook.
- Reaffirmed adjusted operating expenses guidance, suggesting cost control.
- Expected decrease in Surgical Glaucoma segment's unmitigated tariff exposure for full year 2025.
- Focus on achieving reimbursed market access for TearCare procedures could drive future Dry Eye revenue.
- Continued growth in Surgical Glaucoma ordering accounts.
Challenges Ahead
- Full-year 2025 revenue guidance still represents a decline compared to full year 2024.
- Ongoing exposure to tariffs imposed by the U.S. on China impacting cost of goods sold.
- Potential for incremental or unanticipated changes in tariff policies or rates.
- Risks related to changes in reimbursement coverage, payment decisions, or rates for products.
- Unforeseen changes in regulatory requirements and disruptions to the supply chain.
Revenue & Expenses
Visualization of income flow from segment revenue to net income